Preliminary Experience Utilizing Boceprevir with Pegylated Interferon and Ribavirin for Treatment of Recurrent Hepatitis C Genotype 1 after Liver Transplantation

被引：0
|
作者：
Aqel, B. [1 ]
Carey, E. [1 ]
Douglas, D. [1 ]
Byrne, T. [1 ]
Rakela, J. [1 ]
Susan, W. [1 ]
Vargas, H. [1 ]
机构：
[1] Mayo Clin Arizona, Phoenix, AZ USA
来源：
AMERICAN JOURNAL OF TRANSPLANTATION | 2013年 / 13卷
关键词：
D O I：
暂无
中图分类号：
R61 [外科手术学];
学科分类号：
摘要：
引用
收藏
页码：144 / 144
页数：1
相关论文
共 50 条
  • [1] Multicenter Preliminary Experience Utilizing Boceprevir with Pegylated Interferon and Ribavirin for Treatment of Recurrent Hepatitis C Genotype 1 after Liver Transplantation
    Aqel, Bashar
    Koning, Ludi
    Charlton, Michael
    Carey, Elizabeth J.
    Byrne, Thomas J.
    Rakela, Jorge
    Vargas, Hugo E.
    HEPATOLOGY, 2012, 56 : 530A - 530A
  • [2] Treatment of patients with recurrent hepatitis C after liver transplantation with pegylated interferon and ribavirin.
    Samuel, D
    HEPATOLOGY, 2003, 38 (04) : 531A - 531A
  • [3] Pegylated-interferon and ribavirin for recurrent hepatitis C after liver transplantation - A preliminary analysis.
    Mukherjee, S
    Gilroy, RK
    McCashland, TM
    Schafer, DF
    Zetterman, RK
    Sorrell, MF
    HEPATOLOGY, 2002, 36 (04) : 184A - 184A
  • [4] Pegylated interferon-alpha2a/ribavirin treatment of recurrent hepatitis C after liver transplantation
    Dinges, S.
    Morard, I.
    Heim, M.
    Dufour, J.-F.
    Mullhaupt, B.
    Giostra, E.
    Clavien, P. -A.
    Mentha, G.
    Negro, F.
    TRANSPLANT INFECTIOUS DISEASE, 2009, 11 (01) : 33 - 39
  • [5] Initial Experience Utilizing Telaprevir with Peginterferon and Ribavirin for Treatment of Hepatitis C Genotype 1 after Liver Transplantation
    Pungpapong, S.
    Murphy, J.
    Henry, T.
    Satyanarayana, R.
    Rosser, B.
    Yataco, M.
    Harnois, D.
    Patel, T.
    Keaveny, A.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2012, 12 : 430 - 430
  • [6] Ribavirin with either standard or pegylated interferon to treat recurrent hepatitis C after liver transplantation
    Cicinnati, V. R.
    Iacob, S.
    Klein, C. G.
    Baba, H. A.
    Sotiropoulos, G. C.
    Hilgard, P.
    Erim, Y.
    Broelsch, C. E.
    Gerken, G.
    Beckebaum, S.
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2007, 26 (02) : 291 - 303
  • [7] Pegylated interferon ALFA-2A and ribavirin for recurrent hepatitis C after liver transplantation
    Mukherjee, S
    Rogge, DV
    Weaver, L
    Schafer, DF
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2004, 99 (10): : S101 - S101
  • [8] Pegylated interferon alfa-2a and ribavirin for recurrent hepatitis C after liver transplantation
    Mukherjee, S
    TRANSPLANTATION PROCEEDINGS, 2005, 37 (10) : 4403 - 4405
  • [9] Interferon-α and ribavirin for the treatment of recurrent hepatitis C after liver transplantation
    de Vera, ME
    Smallwood, GA
    Rosado, K
    Davis, L
    Martinez, E
    Sharma, S
    Stieber, AC
    Heffron, TG
    TRANSPLANTATION, 2001, 71 (05) : 678 - 686
  • [10] Multicenter Experience Using Telaprevir or Boceprevir With Peginterferon and Ribavirin to Treat Hepatitis C Genotype 1 After Liver Transplantation
    Pungpapong, Surakit
    Aqel, Bashar A.
    Koning, Ludi
    Murphy, Jennifer L.
    Henry, Tanisha M.
    Ryland, Kristen L.
    Yataco, Maria L.
    Satyanarayana, Raj
    Rosser, Barry G.
    Vargas, Hugo E.
    Charlton, Michael R.
    Keaveny, Andrew P.
    LIVER TRANSPLANTATION, 2013, 19 (07) : 690 - 700
12345